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Primary percutaneous coronary intervention (PCI) has been established as the 
treatment of choice for patients presenting with acute ST elevation myocardial 
infarction (STEMI) and is  associated with high success rate, low mortality in 
non-shock patients and low complication rates.  
STEMI  was defined as symptoms of ischemia associated with ST-segment 
elevation of ≥1 mm in limb leads and/or ≥2 mm in chest leads in ≥2 
contiguous leads, or new left bundle branch block, or true posterior myocardial 
infarction with ST depression of ≥1 mm in ≥2 contiguous anterior leads. There 
are no situations in which fibrinolytic therapy is preferred over primary PCI 
unless the patient refuses invasive procedures. Fibrinolytic therapy works 
best when symptom onset is < 3 hours since fresh thrombus lysis more readily 
than more organized, subacute thrombus. If symptoms have been present for 
> 3 hours then primary PCI is preferred.
The best outcomes occur when primary PCI is performed with a door-to-
balloon time of < 90 minutes and when symptoms onset was < 12 hours.
Primary PCI is only indicated when symptoms duration is 12-24 hours
(delayed presentation) if severe congestive heart failure, hemodynamic/
electrical instability or continued angina is present. Primary PCI is not
recommended when symptom onset is more than 12 hours and the patient is
asymptomatic .
Catheterization team was activated immediately on confirmation of STEMI
diagnosis. After loading with dual antiplatelets, patients were immediately
shifted to catheterization laboratory.
After gaining vascular access, non-culprit vessel angiogram was done first
followed by the culprit vessel angiogram. Once the decision to go ahead
with angioplasty was taken, heparin was administered in dosage of 70–
100 U/kg to achieve an ACT of 250–300. GPIIb/IIIa inhibitor use was left to
operator's discretion. The choice of guidewire, balloon, stent, thrombus
aspiration and IABP was on operator's discretion.
Hemodynamically stable patients were kept in CCU for 24–48 h and
subsequently shifted to step down unit and were discharged on 4th or 5th day.
At discharge statinsin dose of 40–80 mg and dual anti platelet (DAPT) agents
were prescribed to all patients. ACEI/ARB and beta blockers were used in all
patients without contraindications for their use.
Important predictors significantly associated with mortality are the door to
balloon time, Killip class, final TIMI flow and severe LV dysfunction.
